Centre Hospitalier Departemental Vendee
Clinical trials sponsored by Centre Hospitalier Departemental Vendee, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a spirometer test guide breathing support in respiratory failure? Results expected Sep 2026 (estimated)
- Could a Two-Drug shot beat the standard for shoulder pain? Results expected Dec 2026 (estimated)
- Tired surgeons, risky surgeries? new study investigates mental fatigue in the operating room Results expected Jan 2027 (estimated)
- Could extra support before and after amputation improve recovery? Results expected Apr 2027 (estimated)
-
Personalized exercise coaching for fibromyalgia: a tiny trial that never got off the ground
Symptom relief Stopped earlyThis study aimed to see if a personalized physical activity program, with one face-to-face session followed by phone coaching, could improve quality of life for people with fibromyalgia compared to standard group exercise classes. The trial was terminated after enrolling only one…
Sponsor: Centre Hospitalier Departemental Vendee • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Sock study stumbles: only one patient enrolled
Symptom relief Stopped earlyThis study tested whether wearing non-slip socks helps older hospital patients walk better. The researchers planned to include people aged 75 and older who needed physical therapy and had poor footwear. However, only one person joined the study, so it was stopped early. No clear …
Sponsor: Centre Hospitalier Departemental Vendee • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Robot seal calms dementia patients during care
Symptom relief Stopped earlyThis study tested whether a robotic seal named PARO could help elderly people with moderate to severe memory problems feel calmer during daily care like bathing. The robot was used for a few minutes before and during care, twice a week for 16 weeks. The goal was to see if it redu…
Sponsor: Centre Hospitalier Departemental Vendee • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Study aims to predict diabetes risk from common transplant drug
Knowledge-focused Stopped earlyThis study looked at how the drug tacrolimus, often used after kidney transplants, affects blood sugar and insulin in people with kidney failure who are waiting for a transplant. Researchers wanted to find early signs of diabetes risk so doctors could adjust treatment. The study …
Phase 4 • Sponsor: Centre Hospitalier Departemental Vendee • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Blood marker study aims to predict preterm birth risk
Knowledge-focused Stopped earlyThis study looked at whether a blood marker called procalcitonin can help predict which pregnant women hospitalized for threatened premature labor will actually deliver early. About 131 women participated, and researchers compared procalcitonin levels between those who gave birth…
Sponsor: Centre Hospitalier Departemental Vendee • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC